Clinical Trial Details
| Trial ID: | L3871 |
| Source ID: | NCT04079881 |
| Associated Drug: | Insulin |
| Title: | Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT04079881/results |
| Conditions: | Type 1 Diabetes|Hyperglycemia, Postprandial |
| Interventions: | DRUG: Insulin |
| Outcome Measures: | Primary: AUC Postprandial Glucagon, Glucagon levels done fasting, 30, 60, 120, and 180 minutes, 4 hours | Secondary: AUC Postprandial Glucose, * Glucose done fasting, 30, 60, 120, and 180 minutes * Glucagon levels done fasting, 30, 60, 120, and 180 minutes * Usual insulin dose will be administered 20 minutes before or after the mixed meal challenge with Ensure Plus\*, 4 hours |
| Sponsor/Collaborators: | Sponsor: Washington University School of Medicine |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1|PHASE2 |
| Enrollment: | 1 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2020-02-13 |
| Completion Date: | 2020-07-01 |
| Results First Posted: | 2022-03-02 |
| Last Update Posted: | 2022-10-07 |
| Locations: | Washington University in St Louis, Saint Louis, Missouri, 63110, United States |
| URL: | https://clinicaltrials.gov/show/NCT04079881 |
